Simultaneous Thermal and Osmotic Stresses in Tumor Ablation: Imaging and Biology
Simultaneous Thermal and Osmotic Stresses in Tumor Ablation: Imaging and Biology
批准号:
9315789
负责人:
ERIK N CRESSMAN
金额:
$37.35万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-14 至 2021-06-30
关键词:
AblationAcetic AcidsAcidsAcuteAddressAdverse effectsAffectBAY 54-9085BiologyCell DeathCell physiologyCellsCellular StressCessation of lifeCharacteristicsChemical Shift ImagingChemicalsChemistryClinicClinicalClinical TrialsCoagulation ProcessCombined Modality TherapyDiseaseDisease ManagementDoseElectrodesEthanolFamily suidaeFundingFutureGoalsImageIn SituIn VitroIncidenceInterventionIonsLeadLeftLiverLocal TherapyMagnetic Resonance ImagingMalignant NeoplasmsMapsMedicalMethodsModelingMolecularMonitorNatural ProductsNecrosisNeedlesOperative Surgical ProceduresOryctolagus cuniculusOutcomePathway interactionsPatient SelectionPatientsPharmaceutical PreparationsPharmacotherapyPrimary carcinoma of the liver cellsProcessRadiofrequency Interstitial AblationReactionRecording of previous eventsRecurrenceResidual stateSaltsSodiumSodium ChlorideSolid NeoplasmSourceStressTechnologyTemperatureTestingTherapeutic EmbolizationThermographyTissuesToxic effectTumor Cell LineTumor TissueUnited Statesbasebiological adaptation to stresscancer typechemical reactioncostcytotoxicityexperimental studyflexibilityimage guidedimprovedimproved outcomein vivoinnovationkillingsmortalityneoplastic cellnovelresponsesynergismsystemic toxicitytemporal measurementtumortumor ablation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Hepatocellular carcinoma is a lethal disease and the fastest growing type of cancer in the United States. Most
patients are not candidates for surgery and medical therapy has only recently achieved a limited survival
benefit of 2-3 months with sorafenib. This drug is costly and has a number of side effects limiting its
acceptance and impact. Locoregional therapies treating tumor in situ likewise have limitations, although the
survival benefit is generally longer. Major clinical weaknesses of existing therapies such as ablation and
embolization are incomplete treatment and local recurrence. In the current proposal, we seek to harness the
exothermic chemical reaction between an acid and a base to release heat and a salt at high local
concentration to kill tumor tissue. We hypothesize that the combination of simultaneous thermal and osmotic
stress is highly effective in killing tumor cells and that the process can be imaged and controlled. In the first aim
we propose to perform MRI temperature imaging to map the thermal dose, combined with multi-gradient echo
recall chemical shift imaging to map the salt with high temporal resolution, and sodium MRI to map the
concentration of the sodium in the treated volume. In the second aim we will perform in vitro experiments on
tumor cell lines to understand how cells respond to this kind of combined stress and interrogate likely pathways
for future intervention. In the final aim we propose to test the concept in vivo using the rabbit VX2 tumor model,
which is large enough to allow for the thermal and sodium imaging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Thermochemical Ablation in Image-Guided Interventions: Initial Assessment
-
批准号:7597107
-
项目类别:
-
资助金额:$19.36万
-
财政年份:2008
-
负责人:ERIK N CRESSMAN
-
依托单位:
Thermochemical Ablation in Image-Guided Interventions: Initial Assessment
-
批准号:7447690
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2008
-
负责人:ERIK N CRESSMAN
-
依托单位:
海外基金